Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,376,429,761
+$117,770,901 QoQ
Shares Held
26,275,718
-3.0% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#14
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. MRK ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
|
59,084,573 | $1,422,756,513 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,376,429,761 | 26,275,718 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,258,658,860 | 27,090,023 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $2,866,718,413 | 27,234,642 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,344,428,520 | 27,933,141 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,275,487,997 | 28,745,427 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,727,883,948 | 30,390,864 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,121,394,599 | 31,377,107 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,050,830,847 | 26,865,365 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $3,320,350,167 | 26,820,276 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $3,575,795,648 | 27,099,626 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,106,159,025 | 28,491,644 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,074,048,186 | 29,859,623 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,308,552,197 | 28,672,781 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,243,306,701 | 30,485,071 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,352,230,317 | 30,213,883 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,574,137,218 | 29,890,121 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,730,512,961 | 29,949,687 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,439,806,387 | 29,735,605 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,300,140,294 | 30,012,269 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,330,507,669 | 31,027,928 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,431,201,642 | 31,261,433 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,473,533,658 | 32,086,293 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $2,688,859,676 | 32,871,160 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,798,765,897 | 33,740,381 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,610,716,372 | 33,760,704 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $2,531,364,877 | 32,900,519 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||